Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
Wong YJ, Nguyen VH, Yang HI, Li J, Le MH, Wu WJ, Han NX, Fong KY, Chen E, Wong C, Rui F, Xu X, Xue Q, Hu XY, Leow WQ, Goh GB, Cheung R, Wong G, Wong VW, Yu MW, Nguyen MH. Wong YJ, et al. Among authors: li j. Clin Mol Hepatol. 2023 Jul;29(3):705-720. doi: 10.3350/cmh.2023.0004. Epub 2023 May 8. Clin Mol Hepatol. 2023. PMID: 37157776 Free PMC article.
Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials.
Gu Y, Sun L, He Y, Yang L, Deng C, Zhou R, Kong T, Zhang W, Chen Y, Li J, Shi J. Gu Y, et al. Among authors: li j. Expert Rev Gastroenterol Hepatol. 2023 Mar;17(3):273-282. doi: 10.1080/17474124.2023.2172397. Epub 2023 Feb 6. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36689199
Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC.
Li T, Guo J, Liu Y, Du Z, Guo Z, Fan Y, Cheng L, Zhang Y, Gao X, Zhao Y, He X, Wu W, Gao N, Wu Y, Li J, Zhang Y, Kang W, Cai Z, Wang W, Li X, Zan Y, Nguyen MH, Ji F. Li T, et al. Among authors: li j, li x. Cancer Immunol Immunother. 2023 Jul;72(7):2137-2149. doi: 10.1007/s00262-023-03404-8. Epub 2023 Feb 25. Cancer Immunol Immunother. 2023. PMID: 36840762 Free PMC article.
Baseline albumin-bilirubin score: a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment.
Zhang Y, Gu Y, Yin S, Wang J, Zhang Z, Liu Y, Chen Y, Zhan J, Xue R, Yan X, Zhang S, Ding W, Chen Y, Li J, Huang R, Wu C. Zhang Y, et al. Among authors: li j. Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):1023-1029. doi: 10.1097/MEG.0000000000002598. Epub 2023 Jun 21. Eur J Gastroenterol Hepatol. 2023. PMID: 37395182
179,472 results
You have reached the last available page of results. Please see the User Guide for more information.